reference/13638381

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13638381

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Research Support, Non-U.S. Gov't
issn	0920-1211
pageRange	106526-
publicationName	Epilepsy Research
startingPage	106526
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a0c77b1373e914b0a28e8883bf3ec4d1
bibliographicCitation	Ben-Menachem E, Baulac M, Hong SB, Cleveland JM, Reichel C, Schulz AL, Wagener G, Brandt C. Safety, tolerability, and efficacy of brivaracetam as adjunctive therapy in patients with focal seizures, generalized onset seizures, or Unverricht-Lundborg disease: An open-label, long-term follow-up trial. Epilepsy Res. 2021 Feb;170():106526. doi: 10.1016/j.eplepsyres.2020.106526. PMID: 33461041.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4cff46c39081653cbcac2d926c66432 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b918e17b31f822eeda83d2b0259836d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e55930e6bc8120acafb836b1ba975561 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2fc7905ed911df91e99af33d2ffe7be0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_87bcca61f60deef5ea53ae2c469d1d34 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8235e9a808fa78b961444db9867ea7a2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53987da3603acfe6c3c60f5d393fabff http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_706d681b27f528c1ed1a54db7959e6c7
date	202102
identifier	https://doi.org/10.1016/j.eplepsyres.2020.106526 https://pubmed.ncbi.nlm.nih.gov/33461041
isPartOf	https://portal.issn.org/resource/ISSN/0920-1211 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Safety, tolerability, and efficacy of brivaracetam as adjunctive therapy in patients with focal seizures, generalized onset seizures, or Unverricht–Lundborg disease: An open-label, long-term follow-up trial
discusses	http://id.nlm.nih.gov/mesh/M0018278 http://id.nlm.nih.gov/mesh/M0001382 http://id.nlm.nih.gov/mesh/M0497062 http://id.nlm.nih.gov/mesh/M0006857
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011760Q000627 http://id.nlm.nih.gov/mesh/D004829Q000188 http://id.nlm.nih.gov/mesh/D012640Q000188 http://id.nlm.nih.gov/mesh/D020194Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D004364 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D000927Q000627 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D004827Q000188 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D011760Q000009
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9837243 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7617 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10474 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191

Total number of triples: 45.